AIM ImmunoTech Adjourns Annual Meeting to December 8
The NYSE American-listed company lacked a stockholder quorum at its November 17, 2026 annual meeting and will reconvene virtually.
Updated on Nov. 18, 2026 in Business

AIM ImmunoTech Inc. adjourned its 2026 Annual Meeting of Stockholders until December 8, 2026, after the November 17 meeting failed to reach a quorum. Proxies had been submitted representing approximately 32.5% of outstanding shares entitled to vote, short of the required threshold.
Why it matters
A quorum requires shares representing 33 and 1/3% of common stock outstanding and entitled to vote, so the shortfall prevented the stockholders from acting on the proposals. Stockholders who already submitted proxies need not act unless they wish to change their vote, and no changes have been made to the proposals.
Proxies representing about 32.5% of outstanding shares entitled to vote were submitted, falling just short of the 33 and 1/3% quorum threshold. The announcement does not say whether additional proxy solicitation is planned before the reconvened session.
The players
AIM ImmunoTech Inc.
AIM ImmunoTech is a biopharmaceutical company trading on the NYSE American under the symbol AIM, headquartered in Ocala, Florida.
The details
The Annual Meeting, originally scheduled for November 17, 2026, was adjourned because too few shares were present or represented by proxy to constitute a quorum. The meeting will reconvene virtually on December 8, 2026 at 11:00 A.M. Eastern Time, and the proposals in the definitive proxy statement filed September 30, 2026 remain unchanged.
Timeline
September 28, 2026: Record date for determining stockholders entitled to vote.
September 30, 2026: Definitive proxy statement filed with the SEC.
November 17, 2026: Annual Meeting convened and adjourned for lack of quorum.
December 8, 2026: Annual Meeting reconvenes virtually at 11:00 A.M. ET.
Season Trajectory
Quorum shortfalls that force adjournment are a recurring feature of proxy-dependent annual meetings, particularly where retail ownership is high and votes must be gathered by mail or online. AIM's reconvened session follows that standard path rather than a change in the proposals themselves.
Stockholders who already voted by proxy do not need to act unless they want to change their vote. Those who have not yet voted may want to submit a proxy or attend the reconvened session to help the company reach quorum.
The takeaway
Voting through proxy still matters even when a meeting is routine, because a missed quorum can delay every proposal on the agenda. Shareholders who have not yet voted should confirm their proxy status before December 8.
What happens next
The Annual Meeting will reconvene virtually on December 8, 2026 at 11:00 A.M. Eastern Time, at which point stockholders may vote if a quorum is reached.
Further reading
For more on companies listed on the exchange, see Public Companies coverage across Ocala.
More information
Stockholders can attend the reconvened meeting through the virtual attendance portal.
Source note: This article includes information reported by The Manila times.






